Picture of Prothena logo

PRTA — Prothena News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapHigh Flyer

Prothena Corporation PLC expected to post a loss of $1.18 a share - Earnings Preview

* Prothena Corporation PLC  PRTA.OQ   PRTA.O  is expected
to show
a fall in quarterly revenue when it reports  results on November
12 for the period ending September 30 2024
    * The Dublin Ireland; Republic of-based   company is
expected to
report a 98.6% decrease in revenue to $1.226 million from $84.87
million a year ago, according to the mean estimate from 8
analysts, based on LSEG data.
    * ​LSEG's mean analyst estimate for Prothena Corporation PLC
is
for a loss of $1.18 per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Prothena
Corporation PLC is $62.00​, above​ its last closing price
of $17.49. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Jun. 30 2024  -1.02       -1.05      1.22      Beat    215.8
 Jan. 1 2024   -1.20       -1.20      -1.34     Missed  -11.6
 Dec. 31 2023  -1.24       -1.22      -1.26     Missed  -3.6​
 Sep. 30 2023  -0.35       -0.32      0.38      Beat    218
 ​​Jun.        -1.10       -1.00      -1.03     Missed  -3.4
 30 2023                                                
 Mar. 31 2023  -0.98       -0.94      -0.89     Beat    5.8​
 Dec. 31 2022  -0.42       -0.47      0.12      Beat    125.8
 Sep. 30 2022  -0.53       -0.53      -0.97     Missed  -83.5
 This summary was machine generated November 8 at 21:41 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)

Recent news on Prothena

See all news